Lv3
336 积分 2024-09-05 加入
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
10个月前
已完结
Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study
10个月前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
10个月前
已完结
HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer
10个月前
已完结
A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients
10个月前
已完结
Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial
11个月前
已完结
皖公网安备34019202002308
